Gilles Goyault

Dr. Gilles Goyault

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2011 in Skeletal Radiology
Verified
Journal Article
Closed access
PDF file
GGGilles Goyault
Gilles Goyault
GBG. Bierry
G. Bierry
NHN. Holl
N. Holl
BLB. Lhermitte
B. Lhermitte
JDJ. L. Dietemann
J. L. Dietemann
SKStéphane Kremer
Stéphane Kremer

13 July 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
KGKévin GUILLEN
Kévin GUILLEN
FTFrederic Thony
Frederic Thony
CGCostantino Del Giudice
Costantino Del Giudice
GGGilles Goyault
Gilles Goyault
DADAVID Arthur
DAVID Arthur
RLRomaric Loffroy
Romaric Loffroy
Excellent outcomes of angioplasty/stenting for the post-thrombotic syndrome (PTS) have been reported, notably regarding objective criteria in the vast French SFICV cohort. Differences may exist between patient-reported and objective outcomes. We investigated this possibility by using validated scales because significative correlations are discordant in the literature between patency and patient-reported characteristics. Patient-reported outcomes seem to be a more consistent tool than radiologic patency for the diagnosis and follow-up of patients displaying PTS. We retrospectively reviewed the Villalta scale and 20-item ChronIc Venous dIsease quality-of-life Questionnaire (CIVIQ-20) scores recorded after endovascular stenting for PTS at 14 centres in France in 2009–2019. We also collected patency rates, pre-operative post-thrombotic lesion severity, and the extent of stenting. We performed multivariate analyses to identify factors independently associated with improvements in each of the two scores. The 539 patients, including 324 women and 235 men, had a mean age of 44.7 years. The mean Villalta scale improvement was 7.0 ± 4.7 (p < 0.0001) and correlated with the thrombosis sequelae grade and time from thrombosis to stenting. The CIVIQ-20 score was available for 298 patients; the mean improvement was 19.2 ± 14.8 (p < 0.0001) and correlated with bilateral stenting, single thrombosis recurrence, and single stented segment. The objective gains demonstrated in earlier work after stenting were accompanied by patient-reported improvements. The factors associated with these improvements differed between the Villalta scale and the CIVIQ-20 score. These results proved that clinical follow-up with validated scores is gainful in patients treated for PTS thanks to a mini-invasive procedure.

1 March 2016 in Journal des Maladies Vasculaires
Verified
Journal Article
Closed access
GGGilles Goyault
Gilles Goyault

6 January 2026 in medRxiv
Verified
Preprint
Open access
PDF file
BSBenedict Stanberry
Benedict Stanberry
KDKoen Deloose
Koen Deloose
YGYann Gouëffic
Yann Gouëffic
GGGilles Goyault
Gilles Goyault
GIGiacomo Isernia
Giacomo Isernia
MSMarc Sirvent
Marc Sirvent
Objective: Rotational percutaneous mechanical thrombectomy with adjunctive angioplasty, stenting or limited thrombolysis (rPMT+) has become commonplace in the treatment of acute and subacute limb ischaemia. This systematic review and proportional meta-analysis synthesises the available evidence on its safety and efficacy. Data Sources: MEDLINE, Embase and the Cochrane Library. ≥ Review Methods: We searched for studies (≥10 patients) published since 1 January 2012 (PROSPERO protocol CRD420251015846). Risk of bias was assessed using RoBANS 2. Proportional meta-analysis maximised representative sample sizes by incorporating both single-arm and comparative studies. GRADE evidence profiles were developed for each outcome of interest. Results: Twenty-four studies – seven comparative and 17 single arm – containing 2,954 procedures (2,697 rPMT+, 257 controls) met eligibility criteria. There were no randomised controlled trials. The pooled technical success (TS) rate for rPMT+ was 98% (95% CI: 97-100%, p <0.001). Amputation-free survival (AFS) was 96% (95% CI: 93-98%, p <0.001). Twelve-month primary patency (PP) was 68% (95% CI: 55-79%, p <0.001). The pooled rate of freedom from clinically-driven target lesion revascularisation (fCDTLR) was 85% (95% CI: 80-90%, p <0.001). No significant differences existed between acute, subacute and mixed subgroups. Procedure-related mortality was 0.5% (11 deaths in 2,086 procedures from 17 studies) with most deaths occurring after adjunctive catheter-directed thrombolysis. Major adverse events occurred in 4% of procedures (95% CI: 1-8%, p <0.001) and distal embolization in 8% (95% CI: 5-11%, p <0.001). rPMT+ reduced length of stay by 1.7 days versus alternatives (95% CI: 3.3-0.1 days, p <0.05). All outcomes demonstrated heterogeneity. GRADE assessment rated evidence certainty as low to very low. Conclusion: rPMT+ delivers consistently high TS and AFS rates, promising 12-month fCDTLR, acceptable PP, low procedural risk and shorter hospital stays than comparators. The consistency of favourable outcomes supports its use as a safe and effective treatment in appropriately selected ALI and SLI patients. WHAT THIS PAPER ADDS: This systematic review and proportional meta-analysis synthesises 24 single-arm and comparative non randomised studies encompassing nearly 3,000 procedures to provide a comprehensive assessment of the safety and efficacy of rotational percutaneous mechanical thrombectomy in patients with acute and subacute lower limb ischaemia. It demonstrates that, when used for initial revascularisation prior to adjunctive angioplasty, stenting or limited thrombolysis, this endovascular approach delivers consistently high rates of technical success and amputation-free survival with notably high rates of freedom from clinically-driven target lesion revascularisation, acceptable primary patency, low procedural risk and significantly shorter hospital stays.